Stocks  /  NASDAQ  /  OSR Holdings Inc.

OSR Holdings Inc.

Industry:   Health Care – Medical/Dental Instruments

Stock Symbol:   OSRHNASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

OSR Holdings, Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company confirms in the following report that they exploit animals for product testing.

“A pre-clinical (non-human) trial of DRT-101 demonstrated cartilage regeneration and joint healing in animals, with no serious adverse events reported. Based on these preliminary results, Darnatein intends to continue the development and testing of DRT-101 and, when additional resources are available, DRT-102.” (Page 7) Read the full document

Company Description

OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. OSR Holdings, Inc. is based in Bellevue, Washington.

Company Website: https://www.osr-holdings.com

Contact:  group@osr-holdings.com
Scroll to Top